Literature DB >> 12949045

Mechanisms underlying DNA damage resistance in a Xiphophorus melanoma cell line.

Steven Moredock1, Rodney S Nairn, Dennis A Johnston, Michelle Byrom, Ginger Heaton, Megan Lowery, David L Mitchell.   

Abstract

The Xiphophorus hybrid fish model is an important resource for investigating the genetics and molecular biology of melanoma. Consistent with studies using human melanoma cell lines, the Xiphophorus melanoma cell line PSM, survives the lethal effects of ultraviolet-B radiation (UV-B) radiation much better than a cell line derived from normal fish tissue. In contrast to human melanoma cells, which show enhanced nucleotide excision repair, we do not see any differences in the efficiencies of photoenzymatic or nucleotide excision repair in normal and melanoma cell lines. We do, however, observe a significantly reduced growth rate in the melanoma cell line compared with the normal cell line and considerably less effect of UV-B radiation on DNA synthesis. The data suggest that the UV resistance phenotype of PSM cells is due more to the rate of proliferation and increased ability to replicate on a damaged template rather than enhanced repair of DNA photoproducts as observed in human melanoma cells. The putative increase in lesion bypass by DNA polymerase could result in higher mutation frequencies and enhanced genetic lability in fish melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949045     DOI: 10.1093/carcin/bgg160

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  1 in total

1.  Subnuclear localization, rates and effectiveness of UVC-induced unscheduled DNA synthesis visualized by fluorescence widefield, confocal and super-resolution microscopy.

Authors:  Agnieszka Pierzyńska-Mach; Aleksander Szczurek; Francesca Cella Zanacchi; Francesca Pennacchietti; Justyna Drukała; Alberto Diaspro; Christoph Cremer; Zbigniew Darzynkiewicz; Jurek W Dobrucki
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.